Mice deficient for δ- and μ-opioid receptors exhibit opposing alterations of emotional responses
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
The role of the opioid system in controlling pain, reward and addiction is well established, but its role in regulating other emotional responses is poorly documented in pharmacology. The mu-, delta- and kappa- opioid receptors (encoded by Oprm, Oprd1 and Oprk1, respectively) mediate the biological activity of opioids. We have generated Oprd1-deficient mice and compared the behavioural responses of mice lacking Oprd1, Oprm (ref. 6) and Oprk1 (ref. 7) in several models of anxiety and depression. Our data show no detectable phenotype in Oprk1-/- mutants, suggesting that kappa-receptors do not have a role in this aspect of opioid function; opposing phenotypes in Oprm-/- and Oprd1-/- mutants which contrasts with the classical notion of similar activities of mu- and delta-receptors; and consistent anxiogenic- and depressive-like responses in Oprd1-/- mice, indicating that delta-receptor activity contributes to improvement of mood states. We conclude that the Oprd1-encoded receptor, which has been proposed to be a promising target for the clinical management of pain, should also be considered in the treatment of drug addiction and other mood-related disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Additionally, agonism of the delta-opioid receptor, the primary receptor target of enkephalin, promotes antidepressant outcomes (80), while delta receptor knockout promotes depressive-like behavior (81).”
From Emerging Role for Nucleus Accumbens Medium Spiny Neuron Subtypes in Depression (2017) · cites this paper as [81]
Citations
Cites
Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat
Pellow, S., Chopin, P., File, S. E., & Briley, M. (1985) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(85)90031-7 · Cited by 5,822
Behavioral despair in mice: a primary screening test for antidepressants.
Porsolt, R. D., Bertin, A., & Jalfre, M. (1977) · PubMed · Cited by 3,320
Drugs of abuse: anatomy, pharmacology and function of reward pathways
Koob, G. F. (1992) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(92)90060-j · Cited by 2,070
Matthes, H. W. D., Maldonado, R., Simonin, F., Valverde, O., Slowe, S., Kitchen, I., Befort, K., Dierich, A., Le Meur, M., Dollé, P., et al. (1996) · Nature · doi:10.1038/383819a0 · Cited by 1,722
Self-citationOpioid-receptor mRNA expression in the rat CNS: anatomical and functional implications
Mansour, A., Fox, C. A., Akil, H., & Watson, S. J. (1995) · Trends in Neurosciences · doi:10.1016/0166-2236(95)93946-u · Cited by 1,292
Wise, R. A. (1996) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(96)80079-1 · Cited by 1,072
Kieffer, B. L., Befort, K., Gaveriaux-Ruff, C., & Hirth, C. G. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.24.12048 · Cited by 1,010
Self-citationTimpl, P., Spanagel, R., Sillaber, I., Kresse, A., Reul, J. M. H. M., Stalla, G. K., Blanquet, V., Steckler, T., Holsboer, F., & Wurst, W. (1998) · Nature Genetics · doi:10.1038/520 · Cited by 919
Lufkin, T., Dierich, A., LeMeur, M., Mark, M., & Chambon, P. (1991) · Cell · doi:10.1016/0092-8674(91)90034-v · Cited by 697
Self-citationDecreased GABAA-receptor clustering results in enhanced anxiety and a bias for threat cues
Crestani, F., Lorez, M., Baer, K., Essrich, C., Benke, D., Laurent, J. P., Belzung, C., Fritschy, J.-M., Lüscher, B., & Mohler, H. (1999) · Nature Neuroscience · doi:10.1038/12207 · Cited by 550
Cited by
Items 501–600 of 692
García-Fuster, M. J., Ferrer‐Alcón, M., Martín, M., Kieffer, B. L., Maldonado, R. J., & García-Sevilla, J. A. (2006) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2006.08.008 · Cited by 10
Self-citationOpioids and the Kidney: A Compendium
Didik, S., Golosova, D., Xu, B., & Staruschenko, A. (2023) · Kidney360 · doi:10.34067/kid.0000000000000291 · Cited by 9
Hebb, A. L. O., Drolet, G., Mendella, P. D., Roach, S. P., Gauthier, M. S., & Zacharko, R. M. (2005) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2005.10.001 · Cited by 9
Ligand-Directed Signaling at the Delta Opioid Receptor
Vicente‐Sánchez, A., & Pradhan, A. A. A. (2017) · Handbook of experimental pharmacology · doi:10.1007/164_2017_39 · Cited by 9
Insights into peptide and protein function: a convergent approach
Roques, B. P. (2001) · Journal of Peptide Science · doi:10.1002/psc.315 · Cited by 9
Guo, J. P., Zhou, D., Li, Y., & Khanh, B. H. (2015) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.1962 · Cited by 9
Predictors of Daily Pain Medication Use in Individuals with Recurrent Back Pain
Sturgeon, J. A., Hah, J. M., Sharifzadeh, Y., Middleton, S. K., Rico, T. J., Johnson, K. A., & Mackey, S. (2017) · International Journal of Behavioral Medicine · doi:10.1007/s12529-017-9686-8 · Cited by 9
Modulation of the central opioid system as an antidepressant target in rodent models
McHugh, K., & Kelly, J. P. (2018) · Progress in brain research · doi:10.1016/bs.pbr.2018.07.003 · Cited by 10
Bailey, A., Weber, D., Zimmer, A., Zimmer, A., Hourani, S. M. O., & Kitchen, I. (2004) · Brain Research · doi:10.1016/j.brainres.2004.06.088 · Cited by 9
Gouardères, C., Kieffer, B. L., & Zajac, J. (2004) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2004.01.002 · Cited by 9
Self-citationOpioid Modulation of Psychomotor Stimulant Effects
Shippenberg, T. S., & Chefer, V. I. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-343-9_7 · Cited by 9
Rodriguez‐Zas, S. L., Nowak, R. A., Antonson, A. M., Rund, L. A., Bhamidi, S., Gomez, A. N., Southey, B. R., & Johnson, R. W. (2024) · Physiological Genomics · doi:10.1152/physiolgenomics.00134.2023 · Cited by 8
Symons-Liguori, A. M., & Vanderah, T. W. (2013) · ACS symposium series · doi:10.1021/bk-2013-1131.ch012 · Cited by 8
A Preliminary Study of the Opioid System and Personality Traits Using Positron Emission Tomography
Rodman, A. M., Deckersbach, T., Chou, T., Kong, J., Gollub, R. L., & Dougherty, D. D. (2017) · Complex Psychiatry · doi:10.1159/000452417 · Cited by 9
Yoo, J., Bailey, A., Ansonoff, M., Pintar, J. E., Matifas, A., Kieffer, B. L., & Kitchen, I. (2010) · Synapse · doi:10.1002/syn.20757 · Cited by 8
Self-citationIn Vitro and In Vivo Metabolism of a Selective δ-Opioid Receptor
Guo, J. P., Gu, C., Zhou, D., Elmore, C. S., Bui, K., & Grimm, S. W. (2011) · Drug Metabolism and Disposition · doi:10.1124/dmd.111.040980 · Cited by 8
Kelty, E. A., & Hulse, G. K. (2017) · International Journal of Mental Health and Addiction · doi:10.1007/s11469-017-9856-6 · Cited by 9
A systems omics-based approach to decode substance use disorders and neuroadaptations
Veerappa, A. M., Pendyala, G., & Guda, C. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.08.016 · Cited by 9
Deo, O., Alvi, S., Pham, V., Christopoulos, A., Thal, D. M., Jörg, M., Capuano, B., Valant, C., & Scammells, P. J. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c01061 · Cited by 7
COVID-19 mRNA Vaccines Preserve Immunogenicity after Re-Freezing
Grau, S., Martín‐García, E., Ferrández, O., Martín, R., Vaquero, S. T., Gimeno, R., Magri, G., & Maldonado, R. J. (2022) · Vaccines · doi:10.3390/vaccines10040594 · Cited by 7
Self-citationRelease of an anti-anxiety peptide in casein hydrolysate with Aspergillus oryzae protease
Takeuchi, Y., Fukunaga, M., Iwatani, S., Miyanaga, K., Adachi, T., & Yamamoto, N. (2022) · Food & Function · doi:10.1039/d2fo01793h · Cited by 7
Rodgers, R. J., Augar, R., Berryman, N., Hansom, C. J., O’Mahony, M. L., Palmer, R. M., Stevens, A., & Tallett, A. J. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0435-y · Cited by 7
Deo, O., Pham, V., Alvi, S., Barnes, N. M., Gondin, A. B., Christopoulos, A., Poole, D. P., Carbone, S., Thal, D. M., Jörg, M., et al. (2025) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5c00280 · Cited by 7
Harda, Z., Spyrka, J., Jastrzębska, K., Szumiec, Ł., Bryksa, A., Klimczak, M., Polaszek, M., Gołda, S., Zajdel, J., Misiołek, K., et al. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108307 · Cited by 6
The Impact of UFP-512 in Mice with Osteoarthritis Pain: The Role of Hydrogen Sulfide
Batallé, G., Bai, X., Balboni, G., & Pol, O. (2023) · Antioxidants · doi:10.3390/antiox12122085 · Cited by 6
Ma, L., Fréret, T., Lange, M., Bourgine, J., Coquerel, A., & Lelong‐Boulouard, V. (2014) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.12072 · Cited by 6
Opioid receptors modulate parallel fiber-Purkinje cell synaptic transmission in mouse cerebellum
Bai, J., Ye, T., Wei, Y., Yang, Y., Yang, H.-M., & Lan, Y. (2021) · Neuroscience Letters · doi:10.1016/j.neulet.2021.136356 · Cited by 6
Pharmacogenetics of Addiction Therapy
Graham, D. P., Harding, M. J., & Nielsen, D. A. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2573-6_16 · Cited by 7
Opioid-Induced Reductions in Amygdala Lateral Paracapsular GABA Neuron Circuit Activity
Ronström, J. W., Johnson, N. L., Jones, S. T., Werner, S. J., Wadsworth, H. A., Brundage, J., Stolp, V., Graziane, N., Silberman, Y., Steffensen, S. C., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24031929 · Cited by 7
Therapeutic Potential of Orally Administered Rubiscolin-6
Karasawa, Y., Miyano, K., Yamaguchi, M., Nonaka, M., Yamaguchi, K., Iseki, M., Kawagoe, I., & Uezono, Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24129959 · Cited by 6
Endogenous opioids, stress, and psychopathology
Hebb, A. L. O., Laforest, S., & Drolet, G. (2005) · Techniques in the behavioral and neural sciences · doi:10.1016/s0921-0709(05)80031-8 · Cited by 7
Öztürk, Y., AYDIN, S., Beis, R., & Herekman-Demir, T. (2006) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2006.03.022 · Cited by 6
Opioid modulation of depression: A focus on imaging studies
Rouine, J., Callaghan, C. K., & O’Mara, S. M. (2018) · Progress in brain research · doi:10.1016/bs.pbr.2018.09.007 · Cited by 6
Zheng, Y., Obeng, S., Reinecke, B. A., Chen, C., Phansalkar, P. S., Walentiny, D. M., Gerk, P. M., Liu‐Chen, L., Selley, D. E., Beardsley, P. M., et al. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.172812 · Cited by 6
Umehara, T., Usumoto, Y., Tsuji, A., Kudo, K., & Ikeda, N. (2011) · Legal Medicine · doi:10.1016/j.legalmed.2011.01.005 · Cited by 6
Antidepressant-like Effects of Delta Opioid Receptor Agonists
Jutkiewicz, E. M., & Woods, J. H. (2003) · CRC Press eBooks · doi:10.1201/9780203025765-23 · Cited by 6
Berbegal-Sáez, P., Gallego‐Landin, I., Macía, J., & Valverde, O. (2025) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2025.174075 · Cited by 5
Self-citationRole for μ-opioid receptor in antidepressant effects of δ-opioid receptor agonist KNT-127
Moriya, Y., Kasahara, Y., Shimada, M., Sakakibara, Y., Fujii, H., Nagase, H., Ide, S., Ikeda, K., Hall, F. S., Uhl, G. R., et al. (2022) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2022.12.008 · Cited by 5
μ-Opioid receptor transcriptional variants in the murine forebrain and spinal cord
Chrószcz, M., Hajto, J., Misiołek, K., Szumiec, Ł., Ziemiańska, M., Radlicka-Borysewska, A., Borczyk, M., Zięba, M., Gołda, S., Siwiec, M., et al. (2024) · Gene · doi:10.1016/j.gene.2024.148890 · Cited by 5
Kajino, K., Sugai, T., Kise, R., Suzuki, R., Tokuda, A., Sekiya, Y., Kakumoto, T., Katamoto, R., Kutsumura, N., Nagumo, Y., et al. (2025) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.c25-00012 · Cited by 5
CB1 Agonism Alters Addiction-Related Behaviors in Mice Lacking Mu or Delta Opioid Receptors
Roeckel, L.-A., Massotte, D., Olmstead, M. C., & Befort, K. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00630 · Cited by 5
Self-citationJr.Devi, G. (2013) · Colloquium Series on Neuropeptides · doi:10.4199/c00082ed1v01y201304npe004 · Cited by 6
Nakagawasai, O., Ambo, A., Takahashi, K., Onogi, H., Nishimura, Y., Okubo, M., Nemoto, W., & Tan–No, K. (2022) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b22-00164 · Cited by 5
Central Amygdala Neuroplasticity in Alcohol Dependence
Roberto, M., & Gilpin, N. W. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-405941-2.00011-0 · Cited by 6
Taylor, P. S., Hamlin, A. S., & Crowley, T. M. (2020) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2019.00290 · Cited by 5
Kaya-Akyüzlü, D., Özkan-Kotiloğlu, S., Danışman, M., Bal, C., Oğur, B., & İspir, G. Z. (2023) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2023.104143 · Cited by 5
Mitolo‐Chieppa, D., Natale, L., Marasciulo, F. L., Salvatore, G. D., Mitolo, C. I., Siro-Brigiani, G., Renna, G. M., & Salvia, M. A. D. (2002) · Autonomic and Autacoid Pharmacology · doi:10.1046/j.1474-8673.2002.00263.x · Cited by 5
Opioid System Involvement in Cannabinoid Tolerance and Dependence
Maldonado, R. J. (1882) · Humana Press eBooks · doi:10.1007/978-1-59259-343-9_12 · Cited by 5
Self-citationKajino, K., Sugai, T., Kakumoto, T., Kise, R., Suzuki, R., Tokuda, A., Sekiya, Y., Katamoto, R., Kutsumura, N., Nagumo, Y., et al. (2025) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.c24-00796 · Cited by 4
Endogenous opioid receptors and the feast or famine of maladaptive feeding
Hickey, A. K. S., & Matikainen‐Ankney, B. A. (2025) · Nature Communications · doi:10.1038/s41467-025-57515-0 · Cited by 4
Owens, F., Carbajal, C., Rodriguez, M., & El‐Hage, N. (2025) · Molecular Therapy · doi:10.1016/j.ymthe.2025.09.028 · Cited by 4
Effects of acute pain medications on posttraumatic stress symptoms in early aftermath of trauma
Grau, A. S., Xie, H., Redfern, R. E., Moussa, M., Wang, X., & Shih, C.-H. (2022) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000413 · Cited by 4
Dean, E., Dominique, A., Palillero, A., Tran, A., Paradis, N. J., & Wu, C. F. (2023) · ACS Omega · doi:10.1021/acsomega.3c01918 · Cited by 4
Tran, L. T., Freeman, K. T., Lunzer, M. M., Portoghese, P. S., & Haskell‐Luevano, C. (2024) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.4c00604 · Cited by 4
Class A GPCRs: Cannabinoid and Opioid Receptor Heteromers
Sierra, S., Gomes, I., & Devi, L. A. (2017) · Springer eBooks · doi:10.1007/978-3-319-60174-8_7 · Cited by 5
Neural Receptors Associated with Depression: A Systematic Review of the Past 10 Years
Câmara, A. B., & Brandão, I. A. (2020) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527319666200715102430 · Cited by 5
Walwyn, W. M., Sánchez-Simón, F. M., Rodríguez, R. E., & Evans, C. J. (2010) · Humana Press eBooks · doi:10.1007/978-1-60761-993-2_7 · Cited by 4
Przewłocki, R., & Almeida, O. F. X. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803592-4.00008-0 · Cited by 5
Zubieta, J.-K. (2008) · Elsevier eBooks · doi:10.1016/b978-012370880-9.00199-7 · Cited by 4
Yoo, J. H., Borsodi, A. D., Tóth, G., Benyhe, S., Gáspár, R., Matifas, A., Kieffer, B. L., Metaxas, A., Kitchen, I., & Bailey, A. (2017) · Neuroscience Letters · doi:10.1016/j.neulet.2017.02.002 · Cited by 3
Self-citationδ Opioid Receptor Inverse Agonists and their In Vivo Pharmacological Effects
Hirayama, S., & Fujii, H. (2020) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026620666200402115654 · Cited by 3
The jeong and haan of Vincent van Gogh: neuropeptides of bondedness and loss
Lee, S. W., Cullen, K. R., Rim, S.-R., & Toddes, C. (2024) · Frontiers in Psychology · doi:10.3389/fpsyg.2024.1432175 · Cited by 3
Genetic Transmission of Behavior and Its Neuroendocrine Correlates
Hambsch, B., Landgraf, R., Czibere, L., & Touma, C. (2009) · Elsevier eBooks · doi:10.1016/b978-008088783-8.00084-x · Cited by 6
Genetically Modified Mice as Tools to Understand the Neurobiological Substrates of Depression
Robledo, P., Martín‐García, E., Aso, E., & Maldonado, R. J. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113196660741 · Cited by 3
Self-citationThe Delta-Opioid System in the Brain: A Neglected Element in Parkinson’s Disease?
Chao, D., & Xia, Y. (2015) · Springer eBooks · doi:10.1007/978-3-319-25495-1_14 · Cited by 3
Evolved Vulnerability to Addiction: The Problem of Opiates
Hill, E. M., Hunt, L. M., & Duryea, D. G. (2017) · Evolutionary psychology · doi:10.1007/978-3-319-60576-0_6 · Cited by 3
Genetic Analysis of the Endogenous Opioid System
Pintar, J. E., & Kieffer, B. L. (2004) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-18934-0_11 · Cited by 3
Self-citationNeurobiology of opioid use disorder
Cucinello‐Ragland, J. A., Lintz, T., & Morón, J. A. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-26504-4.00008-9 · Cited by 2
The Various Functions of Opioids in Pathophysiological Conditions
Gao, H., Chao, D., Villarreal, S. J., Yiu, D., Wen, G., Chen, T., Xia, Y., Yao, F., Wang, Q., & Xia, Y. (2015) · Springer eBooks · doi:10.1007/978-3-319-25495-1_18 · Cited by 2
Current Understanding of the Effects and Potential Clinical Utility of Kratom: A Review
Larsen, I., Zhang, E., & Farahmand, P. (2022) · Journal of Psychiatric Practice · doi:10.1097/pra.0000000000000609 · Cited by 2
A piece of the puzzle is revealed for delta opioid receptor-mediated analgesia
Cahill, C. M., & Taylor, A. M. W. (2011) · Pain · doi:10.1016/j.pain.2011.02.006 · Cited by 2
Mazarati, A. M. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804066-9.00076-6 · Cited by 2
Genetic Influences on Moral Capacity: What Genetic Mutants Can Teach Us
Boniolo, G., & Vezzoni, P. (2006) · Cambridge University Press eBooks · doi:10.1017/cbo9780511498428.007 · Cited by 3
Contribution of CD4+ cells in the emotional alterations induced by endometriosis in mice
Escudero-Lara, A., Cabañero, D., & Maldonado, R. J. (2022) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2022.946975 · Cited by 2
Self-citationTome, J., Ibrahim, N. M., & Cowan, L. (2023) · Current Topics in Medicinal Chemistry · doi:10.2174/0115680266260621231102195044 · Cited by 2
Genetic Dissection of Anxiety and Related Disorders
Lesch, K. (2002) · Wiley eBooks · doi:10.1002/9780470986844.ch13 · Cited by 2
Behavioural and neurogenetic study of mechanisms related to cat odour induced anxiety in rodents
Areda, T. (2006) · DSpace repository (University of Tartu) · Cited by 29
Opioids: molecular basis of action
Levac, B. A. R., O’Dowd, B. F., & George, S. R. (2001) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/00060793-200106000-00010 · Cited by 2
Reduction of Submissive Behavior Model for Antidepressant Drug Testing in Mice
Malatyńska, E., Pinhasov, A., & Knapp, R. J. (2009) · Neuromethods · doi:10.1007/978-1-60761-303-9_15 · Cited by 3
Callaghan, C. K., Rouine, J., Islam, M. N., Eyerman, D. J., Smith, K. L., Blumberg, L. C., Sánchez, C., & O’Mara, S. M. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/769349 · Cited by 2
Li, S., Luo, H., Tang, P., Tian, C., Hu, J., Lu, H., & Shui, W. (2024) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2024.100777 · Cited by 1
Ouyang, R., Jiang, J., Li, W., He, F., Yang, L., Kou, X., Dai, J., Xu, M., Liu, Y., & Zhan, J. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1604600 · Cited by 1
Translational reprogramming of dentate gyrus peptidergic circuitry gates antidepressant efficacy
Oh, S.-J., Jang, J.-H., Roussarie, J.-P., Jang, G.-U., Jeong, M.-S., Jo, Y. S., Shin, C.-H., Choi, H., Lee, K., Yoon, J. H., et al. (2026) · Molecular Psychiatry · doi:10.1038/s41380-026-03461-2 · Cited by 1
New Antidepressant Development in the Treatment of Depression
Spiti, A., Caldirola, D., & Perna, G. (2026) · Advances in experimental medicine and biology · doi:10.1007/978-981-95-6872-7_23 · Cited by 1
Stress, Anxiety, and Cocaine Abuse
Craige, C. P., Enman, N. M., & Unterwald, E. M. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-418679-8.00006-x · Cited by 2
Genetic Studies of Opioid System Function in Mice
Ansonoff, M. A., Wen, T., & Pintar, J. E. (2010) · Humana Press eBooks · doi:10.1007/978-1-60761-993-2_13 · Cited by 1
Genetic Models of Depression and Antidepressant Response
Lucki, I. (2010) · Modern trends in psychiatry · doi:10.1159/000319512 · Cited by 1
Carsten, K., & Selena, E. (2012) · InTech eBooks · doi:10.5772/32239 · Cited by 1
The δ-Opioid Receptor and Stabilization of Brain Ionic Homeostasis in Hypoxia/Ischemia
Chao, D., & Xia, Y. (2015) · Springer eBooks · doi:10.1007/978-3-319-25495-1_6 · Cited by 1
Vollmer, L. L. (2014) · OhioLink ETD Center (Ohio Library and Information Network) · Cited by 1
Receptor Knock-Out and Gene Targeting: Generation of Knock-Out Mice
Sora, I., Ikeda, K., & Mishina, Y. M. (2003) · Humana Press eBooks · doi:10.1385/1-59259-379-8:205 · Cited by 1
Promising Therapeutic Agents: Delta Opioid Receptor Agonists
Bazzari, A. H., & Bazzari, F. H. (2017) · The International Annals of Medicine · doi:10.24087/iam.2017.1.8.252 · Cited by 1
Kwon, A. H., Colloca, L., & Mackey, S. (2023) · Anesthesiology Clinics · doi:10.1016/j.anclin.2023.03.006 · Cited by 1
Cannabis and Parkinson’s Disease
Ross, I. A. (2023) · Springer eBooks · doi:10.1007/978-3-031-35155-6_11 · Cited by 1
Genetic mouse models in opioid research: current status and future directions
Avila-Zozaya, M., & Zachariou, V. (2024) · Journal of Neural Transmission · doi:10.1007/s00702-024-02762-6 · Cited by 1
Semenova, O. G., Vyushina, A. V., Притворова, А. В., Пивина, С. Г., & Ordyan, N. E. (2024) · Известия Российской академии наук Серия биологическая · doi:10.31857/s1026347024020059 · Cited by 1
Vía de señalización del receptor apoptótico Fas en la adicción a opiáceos, La
Fuster, G., & Julià, M. (2005) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona) · Cited by 1
Major Depression and Animals Models
Wong, M. (2005) · Wiley eBooks · doi:10.1002/9783527619672.ch27 · Cited by 2
Dickenson, A. H., & Kieffer, B. L. (2007) · Elsevier eBooks · doi:10.1016/b978-84-8174-949-6.50027-7 · Cited by 1
Self-citationOutline for generation and analysis of opioid receptor knockout mice.
Ichiro, S. O. R. A., IKEDA, K., & MISHINA, Y. (2002) · Folia Pharmacologica Japonica · doi:10.1254/fpj.120.47 · Cited by 1
Metadata
- Authors
- Filliol, D., Ghozland, S., Chluba, J., Martin, M., Matthes, H. W. D., Simonin, F., Befort, K., Gavériaux-Ruff, C., Dierich, A., LeMeur, M., Valverde, O., Maldonado, R., & Kieffer, B. L.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- Universitat Pompeu Fabra (ES)
- Institut de génétique et de biologie moléculaire et cellulaire (FR)
- Corresponding author
- Kieffer, Brigitte L.
- ORCID
- Venue
- Nature Genetics
- Published
- 2000-06
- Volume
- 25
- Issue
- 2
- Pages
- 195-200
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W1505495051
- Cited by
- 672
- References
- 31
- Citations by year
- 2026: 6 · 2025: 12 · 2024: 15 · 2023: 19 · 2022: 18 · 2021: 16 · 2020: 24 · 2019: 29 · 2018: 28 · 2017: 30 · 2016: 41 · 2015: 24 · 2014: 39 · 2013: 35 · 2012: 33
- FWCI
- 9.88
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Neuroendocrine regulation and behavior
- Keywords
- delta opioid receptor, mu-opioid receptor, kappa opioid receptor, OprM, anxiety-like behavior, depression-like behavior, emotion regulation, mood disorders, drug addiction, pain
- MeSH terms
- Animals, Anxiety, Binding Sites, Darkness, Depression, Electroshock, Female, Light, Male, Motor Activity, Naloxone, Naltrexone, Narcotic Antagonists, Phenotype, Sex Characteristics, Swimming, Pain Threshold, Gene Deletion, Receptors, Opioid, mu, Receptors, Opioid, delta, Receptors, Opioid, kappa, Mice, Knockout, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.